Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 29:13:1443.
doi: 10.3389/fnins.2019.01443. eCollection 2019.

Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease

Affiliations
Review

Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease

Nao Yan et al. Front Neurosci. .

Abstract

Iron is an essential transition metal for numerous biologic processes in mammals. Iron metabolism is regulated via several coordination mechanisms including absorption, utilization, recycling, and storage. Iron dyshomeostasis can result in intracellular iron retention, thereby damaging cells, tissues, and organs through free oxygen radical generation. Numerous studies have shown that brain iron overload is involved in the pathological mechanism of neurodegenerative disease including Alzheimer's disease (AD). However, the underlying mechanisms have not been fully elucidated. Ferroptosis, a newly defined iron-dependent form of cell death, which is distinct from apoptosis, necrosis, autophagy, and other forms of cell death, may provide us a new viewpoint. Here, we set out to summarize the current knowledge of iron metabolism and ferroptosis, and review the contributions of iron and ferroptosis to AD.

Keywords: Alzheimer’s disease; ferroptosis; iron metabolism; iron overload; reactive oxygen species.

PubMed Disclaimer

References

    1. Abdalkader M., Lampinen R., Kanninen K. M., Malm T. M., Liddell J. R. (2018). Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front. Neurosci. 12:466. 10.3389/fnins.2018.00466 - DOI - PMC - PubMed
    1. Alim I., Caulfield J. T., Chen Y., Swarup V., Geschwind D. H., Ivanova E., et al. (2019). Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177 1262–1279.e25. 10.1016/j.cell.2019.03.032 - DOI - PubMed
    1. Altamura S., Muckenthaler M. U. (2009). Iron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosis. J. Alzheimers Dis. 16 879–895. 10.3233/JAD-2009-1010 - DOI - PubMed
    1. Angeli J. P. F., Shah R., Pratt D. A., Conrad M. (2017). Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol. Sci. 38 489–498. 10.1016/j.tips.2017.02.005 - DOI - PubMed
    1. Apostolakis S., Kypraiou A. M. (2017). Iron in neurodegenerative disorders: being in the wrong place at the wrong time? Rev. Neurosci. 28 893–911. 10.1515/revneuro-2017-0020 - DOI - PubMed

LinkOut - more resources